tiprankstipranks
Voyageur Pharmaceuticals (TSE:VM)
:VM
Canadian Market

Voyageur Pharmaceuticals (VM) Financial Statements

Compare
13 Followers

Voyageur Pharmaceuticals Financial Overview

Voyageur Pharmaceuticals's market cap is currently $24.06M. The company's EPS TTM is C$-0.011; its P/E ratio is ―; Voyageur Pharmaceuticals is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -2.19KC$ -2.91KC$ -2.25KC$ -1.48KC$ -2.12K
Operating IncomeC$ -1.22MC$ -1.75MC$ -2.05MC$ -848.94KC$ -554.89K
EBITDAC$ -1.22MC$ -1.75MC$ -2.05MC$ -1.12MC$ -550.17K
Net IncomeC$ -1.40MC$ -1.75MC$ -2.05MC$ -1.14MC$ -552.29K
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.08KC$ 31.56KC$ 812.97KC$ 2.97KC$ 75.61K
Total AssetsC$ 2.16MC$ 2.10MC$ 2.57MC$ 1.28MC$ 1.61M
Total DebtC$ 40.00KC$ 25.52KC$ 42.08KC$ 268.41KC$ 138.63K
Net DebtC$ 37.91KC$ -6.04KC$ -770.89KC$ 265.44KC$ 63.02K
Total LiabilitiesC$ 727.88KC$ 630.83KC$ 660.64KC$ 968.85KC$ 852.69K
Stockholders' EquityC$ 1.44MC$ 1.46MC$ 1.91MC$ 306.33KC$ 754.09K
Cash Flow
Free Cash FlowC$ -991.25KC$ -2.00MC$ -2.09MC$ -434.13KC$ -639.64K
Operating Cash FlowC$ -991.25KC$ -1.72MC$ -1.65MC$ -272.19KC$ -637.81K
Investing Cash FlowC$ -174.72KC$ -274.15KC$ -432.08KC$ -151.79KC$ -169.62K
Financing Cash FlowC$ 1.14MC$ 1.21MC$ 2.90MC$ 351.34KC$ 736.12K
Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History

Voyageur Pharmaceuticals Debt to Assets

Voyageur Pharmaceuticals Cash Flow

Voyageur Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis